Day: Day 2: 2025

As advanced data technologies redefine personalized medicine, strategic development and sound policy are essential to realizing their full potential. In this keynote, Stacy Cline Amin, Vice President and Chief Counsel for Global Health Regulatory and Policy at Oracle, will share her perspective on how regulatory innovation, data accessibility, and cross-sector partnerships can shape the future […]

Our scientific understanding and technological development for personalized medicine is way ahead of the policies and practices needed to fully realize the field’s value. Clinical implementation of personalized medicine technologies is fraught with challenges. A community approach to developing and implementing strategies to more consistently and effectively deliver personalized medicine is gaining traction, but there […]

Evidence of clinical utility is central to how payers and providers assess value, set coverage policies, and determine reimbursement for personalized medicine technologies. Experts will discuss the evidentiary standards necessary for bringing personalized medicine technologies to market, and strategies to ensure patients have timely access to innovative biomarker-driven diagnostics and therapies. MODERATOR | Suzanne Belinson, Ph.D., […]

SPEAKER | J. Brian Munroe, Vice President, Government Affairs, Bausch Health Companies Inc.

Sponsored by:

MODERATOR | Okan Ekinci, M.D., Chief Medical Information Officer & Global Head of Digital Technology, Roche Information Solutions, Roche Diagnostics PANELIST | Thomas Brown, M.D., Chief Medical Officer, Sygnomics PANELIST | Aradhana Ghosh, M.D., Vice President, Real-World Data Product Development, Labcorp PANELIST | Apostolia Tsimberidou, M.D., Ph.D., Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University […]

SPEAKER | Lincoln Nadauld, M.D., Ph.D., President & Chief Executive Officer, Culmination Bio